Publication | Closed Access

Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis

InflammationAsthmaAnti-allergic ActivityAllergyAllergy MedicineMedicineMast Cell DisorderImmunologyAllergenPassive Systemic AnaphylaxisSkin AllergyAutoimmunityImmunotherapyPharmacologyHypersensitivity